Cooperative Agreement NU58DP006931

Award Date 6/30/21
Completion Date 6/29/26
Dollars Obligated $3.1M
Awarding Federal Agency
Office of Financial Resources
Federal Grant Program
93.283
Assistance Type
Cooperative Agreement
Place of Performance
St Paul, MN, USA
Similar Awards
This federal Cooperative Agreement award of $600,000 was provided by the Centers for Disease Control and Prevention (CDC) under the CDC Investigations and Technical Assistance program (CFDA 93.283). The award was made to the National Association of Chronic Disease Directors, Inc. (NACDD), a non-profit organization focused on public health, chronic disease prevention, and health promotion. The purpose of this 5-year award, effective September 30, 2024, is to build capacity to increase...
This Cooperative Agreement award for $600,000 from the Centers for Disease Control and Prevention (CDC) under the CDC Investigations and Technical Assistance program (CFDA 93.283) is focused on Building Capacity to Increase Commercial Tobacco Cessation - Component 3. The award recipient is the National Association of Chronic Disease Directors, Inc. (NACDD), a non-profit organization that partners with federal agencies, particularly the CDC, to provide technical assistance, capacity building, and...
This federal Project Grant award of $395,051 from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) is supporting a 2-year research project to evaluate the implementation and short-term impact of a new policy in New Jersey that requires tobacco retailers to sell nicotine replacement therapy (NRT) products. The study aims to: 1) determine whether NRT compliance varies by neighborhood characteristics using store audits and spatial analyses, and 2) explore...
This federal Project Grant award of $667,828.00 from the National Cancer Institute (NCI), under the Cancer Cause and Prevention Research (CFDA 93.393) program, aims to enhance the reach and effectiveness of tobacco cessation treatment for socioeconomically disadvantaged populations. The primary products and services to be delivered include: Adapting the Ask-Advise-Connect (AAC) model, a streamlined screening, brief intervention, and referral to treatment approach, to be implemented in...
The National Cancer Institute (NCI) has awarded Purdue University a 5-year, $129,708 Project Grant under the Cancer Research Manpower program (CFDA 93.398) to examine the impact of local tobacco retail policies on sociodemographic disparities in tobacco use outcomes. The key products and services to be delivered under this grant include: Analyzing the impact of local tobacco retailer licensing (TRL) laws and fees on sociodemographic differences in retailer density by race/ethnicity, income,...
This Project Grant award from the National Cancer Institute (NCI), under the federal Cancer Cause and Prevention Research (CFDA 93.393) program, provides $226,504.00 to George Washington University for a research project titled "Tobacco Use Trajectories and Related Mechanisms Among US Adults and Youth Representing Minority and Intersecting Minority Identities". The project aims to examine differences in tobacco use behaviors and related mechanisms, such as marketing exposure and...
This Project Grant award from the National Institute on Minority Health and Health Disparities (CFDA 93.307 Minority Health and Health Disparities Research) provides $694,771.00 to evaluate strategies for improving smoking cessation among rural populations. The key objectives are to: Determine the efficacy of providing a free nicotine replacement therapy (NRT) starter kit to rural people who smoke, in combination with digital cessation resources, to increase smoking abstinence. For those...
This federal Project Grant award, funded by the National Institutes of Health (NIH) under the Trans-NIH Research Support program (CFDA 93.310), will support a research study on the "Implementation, Reach, and Impact of Court-Ordered Tobacco Corrective Statement Postings at the Point-of-Sale." The $675,599 grant, awarded on September 1, 2024, with a completion date of August 31, 2025, aims to characterize the implementation and reach of court-ordered tobacco corrective statement signage...
The Pennsylvania Department of Health (PADOH) was awarded a $1,345,840 Cooperative Agreement by the Centers for Disease Control and Prevention (CDC) under the Assistance Programs for Chronic Disease Prevention and Control (CFDA 93.945) federal grant program. The award, with an effective date of September 30, 2024 and an ultimate completion date of June 29, 2029, will support PADOH's efforts to provide technical assistance and training to tobacco prevention contractors, service providers, and...
This federal Project Grant award of $188,913, provided by the National Institutes of Health (NIH) Office of the Director under the Family Smoking Prevention and Tobacco Control Act Regulatory Research program (CFDA 93.077), supports research aimed at understanding perceptions of the continuum of risk associated with nicotine-containing products among socioeconomically disadvantaged adult smokers. The research, conducted by Virginia Commonwealth University, has three key objectives: 1)...

COMMERCIAL TOBACCO PREVENTION AND CONTROL-RELATED PUBLIC HEALTH LAW TECHNICAL ASSISTANCE TO CDC AND NTCP FUNDED AND NON-FUNDED PARTNERS. - CIGARETTE SMOKING REMAINS THE LEADING CAUSE OF PREVENTABLE DEATH, KILLING MORE THAN 480,000 AMERICANS EACH YEAR AND LEAVING MILLIONS MORE TO SUFFER FROM CHRONIC DISEASE. MAKING MATTERS WORSE, THE TOLL OF ILLNESS AND DEATH IS CONCENTRATED IN CERTAIN COMMUNITIES. WHILE OVERALL SMOKING RATES HAVE DECLINED IN RECENT YEARS, HEALTH DISPARITIES RELATED TO TOBACCO USE HAVE INCREASED. RACIAL AND ETHNIC MINORITIES, PARTICULARLY AFRICAN AMERICANS AND CERTAIN NATIVE AMERICAN POPULATIONS, BEAR A DISPROPORTIONATE BURDEN OF TOBACCO-RELATED DISEASE. IN ADDITION, STUDIES HAVE FOUND THAT LESBIAN, GAY, BISEXUAL, AND TRANSGENDER INDIVIDUALS ARE SIGNIFICANTLY MORE LIKELY TO SMOKE THAN THEIR NON-LGBT COUNTERPARTS. INDIVIDUALS STRUGGLING WITH MENTAL ILLNESS AND SUBSTANCE ABUSE DISORDERS ALSO USE TOBACCO AT HIGH RATES. TOBACCO-RELATED HEALTH DISPARITIES ARE THE DIRECT RESULT OF THE TOBACCO INDUSTRY?S PREDATORY TARGETING OF SPECIFIC MARGINALIZED COMMUNITIES. THE GROUPS MOST HARMED BY TOBACCO USE ARE INTENTIONALLY TARGETED BY THE INDUSTRY AND LEFT OUT OF PROTECTIVE PUBLIC HEALTH POLICY. OVER OUR TWENTY YEARS OF PROVIDING LEGAL TECHNICAL ASSISTANCE (TA), OUR SERVICES HAVE EVOLVED AND EXPANDED DRAMATICALLY. OUR TEAM OF 18 ATTORNEYS AND POLICY ANALYSTS SUPPORT THE FULL SPECTRUM OF COMMERCIAL TOBACCO CONTROL POLICY CHANGE AT ALL LEVELS OF GOVERNMENT IN THE U.S. WITH SUPPORT FROM MULTIPLE FUNDERS, WE RESPOND TO OVER 1,000 REQUESTS FOR LEGAL TA EVERY YEAR FROM PUBLIC HEALTH ADVOCATES IN ALL 50 STATES. OUR WORK IS STRATEGIC, INFLUENTIAL, AND EQUITY-FOCUSED ? LEADING OUR PARTNERS IN THE IDENTIFICATION AND ELEVATION OF NEW POLICIES AND PRACTICES THAT ARE MOST LIKELY TO END THE COMMERCIAL TOBACCO EPIDEMIC. WE STRIVE TO LEAD THE NATIONAL TOBACCO CONTROL MOVEMENT WHILE SERVING AS A TRUE PARTNER TO TOBACCO CONTROL ORGANIZATIONS AND UNDERSERVED COMMUNITIES. OUR ACTIVITIES IMPROVE PUBLIC HEALTH BY BUILDING CAPACITY FOR POLICY CHANGE AND ENGAGING THE PUBLIC HEALTH COMMUNITY IN STRATEGIC DIALOGUE TO END THE TOBACCO EPIDEMIC. WORKING ON EVERY TYPE OF TOBACCO-RELATED ISSUE, WE WILL SUPPORT NTCP-FUNDED AND -NON-FUNDED PARTNERS IN MAKING EFFECTIVE, EVIDENCE-BASED POLICY SOLUTIONS THE HEART OF COMPREHENSIVE TOBACCO CONTROL THAT ADVANCES HEALTH EQUITY BY REDUCING TOBACCO-CAUSED HEALTH DISPARITIES. BY THE END OF THE 5-YEAR PROJECT PERIOD, WE WILL INCREASE NTCP-FUNDED AND -NON-FUNDED PARTNERS?: AWARENESS AND UNDERSTANDING OF PUBLIC HEALTH LAW AND EVIDENCE-BASED TOBACCO CONTROL POLICY INTERVENTIONS; ATTENDANCE AT WORKSHOPS, PRESENTATIONS, AND WEBINARS ON EVIDENCE-BASED TOBACCO CONTROL POLICY INTERVENTIONS; USE AND DISSEMINATION OF TRAINING RESOURCES AND SUPPORT MATERIALS ON KEY PUBLIC HEALTH LAW ISSUES RELATED TO TOBACCO CONTROL POLICY; USE AND DISSEMINATION OF BRIEFING DOCUMENTS, FACT SHEETS, AND OTHER RESOURCES TO EDUCATE DECISION-MAKERS; AND USE OF TA ON TOBACCO CONTROL POLICY ISSUES. WORKING IN PARTNERSHIP WITH THE CDC NATIONAL NETWORKS, WE WILL PROVIDE INTENSIVE, EQUITY-FOCUSED LEGAL TECHNICAL ASSISTANCE AND DEVELOP TOBACCO CONTROL POLICY RESOURCES DESIGNED TO REDUCE TOBACCO-CAUSED DISPARITIES IN PRIORITY POPULATIONS. WE ALSO WILL INCREASE FEDERAL, STATE, AND LOCAL CAPACITY TO REDUCE TOBACCO-RELATED DEATH AND DISABILITY THROUGH EFFECTIVE POLICY DEVELOPMENT, IMPLEMENTATION, AND ENFORCEMENT; THE USE OF EFFECTIVE, EVIDENCE-BASED APPROACHES FOR TOBACCO PREVENTION AND CONTROL POLICIES, INCLUDING INCREASED APPLICATION OF CDC?S BEST PRACTICES FOR COMPREHENSIVE TOBACCO CONTROL PROGRAMS AT THE STATE AND LOCAL LEVEL; AND THE PERCENTAGE OF THE U.S. POPULATION COVERED BY SMOKE-FREE POLICIES AND EVIDENCE-BASED PRICING POLICIES FOR TOBACCO PRODUCTS.

Posted 5/18/21, 12:00 AM